217 related articles for article (PubMed ID: 21953276)
1. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Grote VA; Rohrmann S; Nieters A; Dossus L; Tjønneland A; Halkjær J; Overvad K; Fagherazzi G; Boutron-Ruault MC; Morois S; Teucher B; Becker S; Sluik D; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Molina-Montes E; Dorronsoro M; Huerta JM; Ardanaz E; Jeurnink SM; Beulens JW; Peeters PH; Sund M; Ye W; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen N; Crowe F; Jenab M; Romieu I; Michaud DS; Riboli E; Romaguera D; Bueno-de-Mesquita HB; Kaaks R
Diabetologia; 2011 Dec; 54(12):3037-46. PubMed ID: 21953276
[TBL] [Abstract][Full Text] [Related]
2. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
3. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
[TBL] [Abstract][Full Text] [Related]
4. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
[TBL] [Abstract][Full Text] [Related]
5. High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Oct; 29(10):1285-90. PubMed ID: 22486679
[TBL] [Abstract][Full Text] [Related]
6. Earlier triple therapy with pioglitazone in patients with type 2 diabetes.
Charpentier G; Halimi S;
Diabetes Obes Metab; 2009 Sep; 11(9):844-54. PubMed ID: 19614944
[TBL] [Abstract][Full Text] [Related]
7. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
[TBL] [Abstract][Full Text] [Related]
8. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).
Khaw KT; Wareham N; Luben R; Bingham S; Oakes S; Welch A; Day N
BMJ; 2001 Jan; 322(7277):15-8. PubMed ID: 11141143
[TBL] [Abstract][Full Text] [Related]
9. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
10. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults.
Sung KC; Rhee EJ
Diabet Med; 2007 Aug; 24(8):848-54. PubMed ID: 17650158
[TBL] [Abstract][Full Text] [Related]
11. Relationship between glycated haemoglobin levels and mean glucose levels over time.
Nathan DM; Turgeon H; Regan S
Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
[TBL] [Abstract][Full Text] [Related]
12. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study.
Pajunen P; Peltonen M; Eriksson JG; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J; Lindström J;
Diabet Med; 2011 Jan; 28(1):36-42. PubMed ID: 21166843
[TBL] [Abstract][Full Text] [Related]
13. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
[TBL] [Abstract][Full Text] [Related]
14. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
[TBL] [Abstract][Full Text] [Related]
15. Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolk cohort: implications for preventive strategies.
Chamnan P; Simmons RK; Forouhi NG; Luben RN; Khaw KT; Wareham NJ; Griffin SJ
Diabetes Care; 2011 Apr; 34(4):950-6. PubMed ID: 20622160
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7).
Heianza Y; Arase Y; Fujihara K; Hsieh SD; Saito K; Tsuji H; Kodama S; Yahagi N; Shimano H; Yamada N; Hara S; Sone H
Diabetes Care; 2012 May; 35(5):1050-2. PubMed ID: 22456865
[TBL] [Abstract][Full Text] [Related]
17. Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus.
Neuhold S; Resl M; Huelsmann M; Strunk G; Adlbrecht C; Rath C; Prager R; Luger A; Clodi M; Pacher R
Eur J Clin Invest; 2011 Dec; 41(12):1292-8. PubMed ID: 21615391
[TBL] [Abstract][Full Text] [Related]
18. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
Karl D; Zhou R; Vlajnic A; Riddle M
Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
[TBL] [Abstract][Full Text] [Related]
19. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
[TBL] [Abstract][Full Text] [Related]
20. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
